MEFTAL® – MR Tablets

MUSCLE RELAXANTS INCL. COMB > MEFTAL® – MR Tablets
For The Use Of A Registered Medical Practitioner, A Hospital Or A Laboratory Only.
COMPOSITION
MEFTAL – MR Tablets
Each Uncoated Tablet Contains:
Mefenamic acid IP	500 mg
Tizanidine HCl IP equivalent to Tizanidine	2 mg

INDICATIONS
MEFTAL-MR is indicated for short-term treatment of acute musculoskeletal disorders such as low backache, sprains, strains, sciatica, lumbago, torticollis occurring in adults.
DOSAGE AND ADMINISTRATION
Oral: The usual dose of MEFTAL-MR is one tablet to be taken three times daily with adequate amounts of water, preferably after food or snacks. The treatment lasts for 4-5 days. The drug is not to be continued for longer than seven days.
HOW SUPPLIED
10 Tablets per strip.

Related products